Kostantinos Triantafyllias

Learn More
Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). These manifestations usually co-occur (for practical purpose complete forms) in the same patient, but cases with only 1 or 2 of these findings (for(More)
Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD), an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). Recently, we organized an international collaborative group called American and European NEtwork of Antisynthetase Syndrome (AENEAS) for the study of(More)
The aim of the rheumatology network ADAPTHERA ("risk-adapted rheumatology therapy") is to achieve a comprehensive improvement in rheumatology care by coordinating treatment in a regional, trans-sectoral network. Accompanying biomedical research projects, training concepts, and the construction of a rheumatology register (gathering data and biomaterials)(More)
The clinical picture of enlarged submandibular gland and/or enlarged lacrimal gland often leads to difficulties in differential diagnostics. From the perspective of rheumatology Sjögren's syndrome should be excluded especially in patients who complained of xerophthalmia and xerostomia for longer than 3 months. In this article the authors report the case of(More)
Ziel des Rheuma-Netzwerks ADAPTHERA („risikoadaptierte Rheumatherapie“) ist es, eine flächendeckende Verbesserung der rheumatologischen Versorgung durch Koordination der Behandlung in einem landesweiten, transsektoralen Netzwerk zu erreichen. Begleitende biomedizinische Forschungsprojekte, Schulungskonzepte sowie der Aufbau eines Rheumaregisters (Daten- und(More)
  • 1